4.5 Article

Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy

Journal

NEUROSCIENCE
Volume 146, Issue 3, Pages 1232-1244

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2007.01.065

Keywords

plasticity; G-protein-coupled receptor; immunohistochemistry; [S-35]GTP gamma S autoradiography; [H-3]WIN55; 212-2 autoradiography; neuroexcitability

Categories

Funding

  1. NIDA NIH HHS [P50 DA005274-200016, DA05274, DA14277, P50 DA005274, DA07027, T32 DA007027, R01 DA011322, R01 DA014277] Funding Source: Medline
  2. NINDS NIH HHS [R01 NS052529, R01-NS23350, R01 NS023350, R01 NS052529-02, P30 NS047463, P50-NS25630, R01-NS052529, P50 NS025630, P50 NS025630-150001, R01 NS023350-20] Funding Source: Medline
  3. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

Activation of the cannabinoid type 1 (CB1) receptor, a major G-protein-coupled receptor in brain, acts to regulate neuronal excitability and has been shown to mediate the anticonvulsant effects of cannabinoids in several animal models of seizure, including the rat pilocarpine model of acquired epilepsy. However, the long-term effects of status epilepticus on the expression and function of the CB1 receptor have not been described. Therefore, this study was initiated to evaluate the effect of status epilepticus on CB1 receptor expression, binding, and G-protein activation in the rat pilocarpine model of acquired epilepsy. Using immunohistochemistry, we demonstrated that status epilepticus causes a unique redistribution of hippocampal CB1 receptors, consisting of specific decreases in CB1 immunoreactivity in the dense pyramidal cell layer neuropil and dentate gyrus inner molecular layer, and increases in staining in the CA1-3 strata oriens and radiatum. In addition, this study demonstrates that the redistribution of CB1 receptor expression results in corresponding functional changes in CB1 receptor binding and G-protein activation using [H-3] R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]-1,4-benzoxazin-yl](1-napthalen-yl)methanone mesylate (WIN55,212-2) and agonist-stimulated [S-35]GTP gamma S autoradiography, respectively. The redistribution of CB1 receptor-mediated [S-35]GTP gamma S binding was 1) attributed to an altered maximal effect (E-max) of WIN55,212-2 to stimulate [S-35]GTP-gamma S binding, 2) reversed by the CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride (SR141716A), 3) confirmed by the use of other CB1 receptor agonists, and 4) not reproduced in other G-protein-coupled receptor systems examined. These results demonstrate that status epilepticus causes a unique and selective reorganization of the CB1 receptor system that persists as a permanent hippocampal neuronal plasticity change associated with the development of acquired epilepsy. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available